Intracranial Delivery of Recombinant Nerve Growth Factor: Release Kinetics and Protein Distribution for Three Delivery Systems
- 1 January 1999
- journal article
- Published by Springer Nature in Pharmaceutical Research
- Vol. 16 (2) , 232-240
- https://doi.org/10.1023/a:1018824324275
Abstract
Purpose. Three different polymeric delivery systems, composed of either poly(ethylene-co-vinyl acetate) (EVAc) or poly(lactide-co-gly-colide) (PLGA), were used to administer recombinant human nerve...Keywords
This publication has 26 references indexed in Scilit:
- Topical Treatment with Nerve Growth Factor for Corneal Neurotrophic UlcersNew England Journal of Medicine, 1998
- Pharmacokinetics of interstitial delivery of carmustine, 4-hydroperoxycyclophosphamide, and paclitaxel from a biodegradable polymer implant in the monkey brain.1998
- Transport and elimination of recombinant human NGF during long-term delivery to the brainBrain Research, 1996
- A month–long effect from a single injection of microencapsulated human growth hormoneNature Medicine, 1996
- Neurotrophins and cytokines—intermediaries between the immune and nervous systemsInternational Journal of Developmental Neuroscience, 1995
- The effect of systemically administered recombinant human nerve growth factor in healthy human subjectsAnnals of Neurology, 1994
- Neurotrophic factors: from molecule to manTrends in Neurosciences, 1994
- Microencapsulated nerve growth factor: Effects on the forebrain neurons following devascularizing cortical lesionsNeuroscience Letters, 1992
- Sustained Release of Nerve Growth Factor from Biodegradable Polymer MicrospheresNeurosurgery, 1992
- Human nerve growth factor prevents degeneration of basal forebrain cholinergic neurons in primatesAnnals of Neurology, 1991